CFP
Curran Financial Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Sell |
2,215
-159
| -7% | -$29.5K | 0.09% | 89 |
|
|
2025
Q1 | $497K | Buy |
2,374
+1
| +0% | +$210 | 0.12% | 65 |
|
|
2024
Q4 | $422K | Buy |
2,373
+439
| +23% | +$78K | 0.11% | 67 |
|
|
2024
Q3 | $382K | Buy |
1,934
+8
| +0.4% | +$1.58K | 0.11% | 68 |
|
|
2024
Q2 | $330K | Buy |
1,926
+89
| +5% | +$15.3K | 0.11% | 66 |
|
|
2024
Q1 | $335K | Sell |
1,837
-69
| -4% | -$12.6K | 0.12% | 66 |
|
|
2023
Q4 | $313K | Sell |
1,906
-10
| -0.5% | -$1.64K | 0.12% | 63 |
|
|
2023
Q3 | $286K | Buy |
1,916
+48
| +3% | +$7.16K | 0.12% | 58 |
|
|
2023
Q2 | $252K | Sell |
1,868
-19
| -1% | -$2.56K | 0.11% | 64 |
|
|
2023
Q1 | $301K | Buy |
1,887
+8
| +0.4% | +$1.28K | 0.14% | 55 |
|
|
2022
Q4 | $304K | Sell |
1,879
-213
| -10% | -$34.4K | 0.15% | 57 |
|
|
2022
Q3 | $281K | Sell |
2,092
-7
| -0.3% | -$940 | 0.14% | 52 |
|
|
2022
Q2 | $321K | Buy |
2,099
+24
| +1% | +$3.67K | 0.15% | 49 |
|
|
2022
Q1 | $336K | Sell |
2,075
-219
| -10% | -$35.5K | 0.14% | 61 |
|
|
2021
Q4 | $311K | Buy |
+2,294
| New | +$311K | 0.13% | 58 |
|